The best indicator for Fiserv (FISV)
We backtested 20 indicators across daily, weekly and hourly charts on real Fiserv (FISV) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
Bollinger Mean-Reversion
On the daily chart, this is the strongest risk-adjusted edge we found for Fiserv (FISV) over ~39.7 years — trailing buy-and-hold by 4.6% CAGR.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | Bollinger Mean-Reversion ✓ | Daily | 9.6% | 0.59 | -44.4% | 73.0% | 174 | -4.6% |
| 2 | Holy Grail Confluence ✓ | Daily | 9.1% | 0.55 | -71.8% | 87.0% | 54 | -5.2% |
| 3 | Stochastic ✓ | Daily | 8.8% | 0.52 | -50.0% | 75.0% | 188 | -5.5% |
| 4 | Williams %R ✓ | Daily | 9.0% | 0.51 | -47.4% | 70.7% | 276 | -5.2% |
| 5 | CCI ✓ | Daily | 9.0% | 0.5 | -71.8% | 74.3% | 210 | -5.2% |
| 6 | WaveTrend (8/6/4) ✓ | Daily | 9.4% | 0.49 | -75.9% | 73.6% | 148 | -4.9% |
| 7 | SMA 50/200 Cross ✓ | Daily | 8.7% | 0.45 | -51.5% | 51.9% | 27 | -5.5% |
| 8 | Money Flow Index ✓ | Daily | 7.3% | 0.45 | -54.3% | 83.9% | 56 | -7.0% |
| 9 | EMA 20/50 Cross ✓ | Weekly | 11.7% | 0.57 | -50.7% | 63.6% | 11 | -2.4% |
| 10 | EMA 50/200 Cross ✓ | Daily | 7.3% | 0.4 | -60.1% | 41.4% | 29 | -6.9% |
| 11 | RSI Trend (>50) ✓ | Weekly | 5.4% | 0.35 | -73.8% | 45.0% | 120 | -8.8% |
| 12 | Donchian Breakout ✓ | Weekly | 4.7% | 0.34 | -54.5% | 56.2% | 32 | -9.5% |
| 13 | CCI | Weekly | 4.6% | 0.34 | -69.3% | 82.9% | 35 | -9.6% |
| 14 | Williams %R | Weekly | 4.6% | 0.33 | -74.2% | 82.4% | 51 | -9.5% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For Fiserv (FISV), Bollinger Mean-Reversion on the daily timeframe gave the best balance of return and risk in our test. It still trailed buy-and-hold on raw return — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.